Table 2.
Side effects.
| Study | Silymarin group | N | Placebo | N | ||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| Velussi et al. 1997 [26] | 2.16 ep/pac/an hypoglycemic event | 2.2 ep/pac/an hypoglycemic event | ||||
| No side effects | ||||||
|
| ||||||
| Huseini et al. 2006 [28] | Not reported | |||||
|
| ||||||
| Hussain 2007 [29] | No side effects | |||||
|
| ||||||
| Fallahzadeh et al. 2012 [19] | Nausea and vomiting | 3 (10%) | 28 | Nausea and vomiting | 2 (6.7%) | 28 |
| Headache | 2 (6.7%) | 28 | Headache | 0 (0%) | 28 | |
| Dyspepsia and bloating | 1 (3.3%) | 28 | Dyspepsia and bloating | 0 (0) | 28 | |
|
| ||||||
| Ebrahimpour Koujan et al., 2015 [30] | No side effects | |||||